Search

Husheng Yang Phones & Addresses

  • 7 Maureen Ct, Wilmington, DE 19808 (302) 683-0659
  • Greenville, DE
  • 374 Taylor Ave, Moscow, ID 83843
  • New Castle, DE
  • 521 Stanford, Irvine, CA 92612 (949) 509-7346
  • 7 Maureen Ct, Wilmington, DE 19808

Work

Company: Gsk Apr 1, 2014 Position: Senior scientific investigator, chemometrician

Education

Degree: Master of Science, Masters School / High School: Peking University Specialities: Chemistry

Skills

Spectroscopy • Analytical Chemistry • Chemometrics • Chemistry • R&D • Pharmaceuticals • Pharmaceutical Development

Industries

Pharmaceuticals

Resumes

Resumes

Husheng Yang Photo 1

Senior Scientific Investigator, Chemometrician

View page
Location:
Wilmington, DE
Industry:
Pharmaceuticals
Work:
Gsk
Senior Scientific Investigator, Chemometrician

Astrazeneca Oct 2010 - Mar 2014
Senior Technical Director, Global Technical Services, Operations

Astrazeneca Jul 2006 - Sep 2010
Associate Principal Scientist of Chemometrics, Par and D

Astrazeneca Jan 2004 - Jun 2006
Associate Principal Scientist of Chemometrics and Vibrational Spectroscopy, Par and D
Education:
Peking University
Master of Science, Masters, Chemistry
University of Idaho
Doctorates, Doctor of Philosophy, Chemistry
Peking University
Bachelors, Bachelor of Science
Skills:
Spectroscopy
Analytical Chemistry
Chemometrics
Chemistry
R&D
Pharmaceuticals
Pharmaceutical Development

Publications

Us Patents

Extended Release Formulations Comprising Quetiapine And Methods For Their Manufacture

View page
US Patent:
20110319383, Dec 29, 2011
Filed:
Nov 16, 2007
Appl. No.:
12/599861
Inventors:
Daniel Brown - Wilmington DE, US
Donna Caster - Wilmington DE, US
Brian Clark - Cheshire, GB
Sandra Hopkins - Wilmington DE, US
Jennifer Llewelyn - Wilmington DE, US
Lisa Martin - Wilmington DE, US
Elizabeth Meehan - Cheshire, GB
Robert Timko - Wilmington DE, US
Husheng Yang - Wilmington DE, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/554
A61P 25/18
US Classification:
51421113
Abstract:
The present invention relates to extended release formulations of quetiapine and its pharmaceutically acceptable salts. The formulations comprise polymers, preferably hydroxypropyl methylcellulose of different viscosities, selected to cause the formulations to conform to preselected quetiapine release profiles. A process for the manufacture of said formulations is also disclosed.

Extended Release Compositions And Methods For Their Manufacture

View page
US Patent:
20080287418, Nov 20, 2008
Filed:
Nov 14, 2007
Appl. No.:
11/939585
Inventors:
Daniel Brown - Wilmington DE, US
Donna Caster - Wilmington DE, US
Brian Clark - Macclesfield, GB
Sandra Hopkins - Wilmington DE, US
Jennifer Llewelyn - Wilmington DE, US
Elizabeth Meehan - Macclesfield, GB
Lisa Martin - Wilmington DE, US
Robert Timko - Wilmington DE, US
Husheng Yang - Wilmington DE, US
Assignee:
ASTRAZENECA AB - Sodertalje
International Classification:
A61K 31/554
A61P 25/18
US Classification:
51421113
Abstract:
Extended release formulations of quetiapine and its pharmaceutically salts, and methods for manufacture of the formulations, may include the use of polymers selected for their physical and chemical characteristics. The formulations may include polymers selected to cause solid dosage forms of the formulations to conform to preselected quetiapine release criteria. The formulations may include non-polymer materials that may affect quetiapine release.
Husheng A Yang from Wilmington, DE, age ~61 Get Report